Cargando…
Novel biomarkers for diabetic kidney disease
Although diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in patients with diabetes mellitus; its prevalence has failed to decline over the past 30 years. To identify those at high risk of developing DKD and disease progression at an early stage, extensive research...
Autores principales: | Jung, Chan-Young, Yoo, Tae-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Nephrology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590299/ https://www.ncbi.nlm.nih.gov/pubmed/36239061 http://dx.doi.org/10.23876/j.krcp.22.084 |
Ejemplares similares
-
Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease
por: Jung, Chan-Young, et al.
Publicado: (2022) -
Novel Biomarkers of Diabetic Kidney Disease
por: Rico-Fontalvo, Jorge, et al.
Publicado: (2023) -
Novel biomarkers for prognosticating diabetic kidney disease progression
por: Swaminathan, Shilna Muttickal, et al.
Publicado: (2022) -
Biomarkers of diabetic kidney disease
por: Colhoun, Helen M., et al.
Publicado: (2018) -
Urinary angiotensinogen as a marker of elevated blood pressure in patients with chronic kidney disease
por: Jung, Chan-Young, et al.
Publicado: (2021)